OraSure Technologies, Inc.

OSUR Healthcare Medical Instruments & Supplies

OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.61 0.20 −5.25%
Market cap
$262.8M
P/E
0.0×
Fwd P/E
−3.9×
Dividend yield
—
F-score
3/9
Altman Z
1.47
Beneish M
−2.73
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
2.74 1.85 1.55 1.86
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(31.02) (15.04) (19.77) (23.27)
P/B ratio
0.97 0.67 0.52 0.65
EV/Sales
1.31 0.29 (0.19) 0.14
EV/EBITDA
0.00 0.00 0.35 0.00
EV/FCF
(3.02) (0.66) 0.40 (0.42)
Current Ratio
8.88 5.46 6.58 7.03
Net Debt/EBITDA
(20.54) 8.45 11.25 15.87
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(15.47%) (34.67%) (38.43%) (24.92%)
Free Cash Flow Yield
(15.87%) (23.28%) (29.93%) (18.25%)
Free Cash Flow per Share
(0.18) (0.21) (0.15) (0.15)
Book value per Share
4.61 4.50 4.64 4.96
Free Cash Flow
(12.33) (14.81) (10.81) (10.89)
EV/EBIT
0.00 0.00 0.30 0.00
Other line items

Show all line items

Columns are period end dates